TY - JOUR
T1 - Mucinous Adenocarcinoma of the Salivary Gland
T2 - A Review of a Rare Tumor
AU - Farhood, Zachary
AU - Zhan, Kevin Y.
AU - Lentsch, Eric J.
N1 - Publisher Copyright:
© American Academy of Otolaryngology-Head and Neck Surgery Foundation 2016.
PY - 2016/5
Y1 - 2016/5
N2 - Objective To describe the clinical, demographic, and prognostic features of salivary gland mucinous adenocarcinoma, a rare head and neck malignancy. Study Design Population-based national cancer registry analysis. Setting Academic medical center. Subjects and Methods A review was performed with the National Cancer Database from 1998 to 2012. Demographic, clinical, and survival characteristics were compiled and analyzed. Cox multivariate regression was used to identify predictors of survival. Log-rank tests were used to test survival differences unless otherwise specified. Results A total of 170 cases were identified. The most common site of involvement was the parotid gland. Rates of nodal and distant metastases were 45.9% and 10.6%, respectively. High histologic grade was associated with nodal disease (P <.001) and advanced-stage disease (P =.006). Overall 5- and 10-year survival rates were 60% and 44%, respectively. Multivariate analysis found tumor size ≥2 cm (hazard ratio, 22.6; 95% confidence interval: 4.06-126.09; P <.001) and distant metastases (hazard ratio, 17.6; 95% confidence interval: 3.75-82.68; P <.001) to predict poor outcomes. Conclusions Mucinous adenocarcinoma of the salivary gland is a rare otolaryngic cancer. Regional metastases and advanced stage are more common with high histologic grade. Tumor size and distant metastases negatively influence survival.
AB - Objective To describe the clinical, demographic, and prognostic features of salivary gland mucinous adenocarcinoma, a rare head and neck malignancy. Study Design Population-based national cancer registry analysis. Setting Academic medical center. Subjects and Methods A review was performed with the National Cancer Database from 1998 to 2012. Demographic, clinical, and survival characteristics were compiled and analyzed. Cox multivariate regression was used to identify predictors of survival. Log-rank tests were used to test survival differences unless otherwise specified. Results A total of 170 cases were identified. The most common site of involvement was the parotid gland. Rates of nodal and distant metastases were 45.9% and 10.6%, respectively. High histologic grade was associated with nodal disease (P <.001) and advanced-stage disease (P =.006). Overall 5- and 10-year survival rates were 60% and 44%, respectively. Multivariate analysis found tumor size ≥2 cm (hazard ratio, 22.6; 95% confidence interval: 4.06-126.09; P <.001) and distant metastases (hazard ratio, 17.6; 95% confidence interval: 3.75-82.68; P <.001) to predict poor outcomes. Conclusions Mucinous adenocarcinoma of the salivary gland is a rare otolaryngic cancer. Regional metastases and advanced stage are more common with high histologic grade. Tumor size and distant metastases negatively influence survival.
KW - head and neck cancer
KW - mucinous adenocarcinoma
KW - salivary gland tumor
UR - http://www.scopus.com/inward/record.url?scp=84968860942&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84968860942&partnerID=8YFLogxK
U2 - 10.1177/0194599816630546
DO - 10.1177/0194599816630546
M3 - Article
C2 - 26908552
AN - SCOPUS:84968860942
SN - 0194-5998
VL - 154
SP - 875
EP - 879
JO - Otolaryngology - Head and Neck Surgery (United States)
JF - Otolaryngology - Head and Neck Surgery (United States)
IS - 5
ER -